Glimepiride and Xopenex hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glimepiride (glimepiride) and Xopenex hfa (levalbuterol tartrate). Common drug interactions include bronchitis chronic among females and coma among males.

The phase IV clinical study analyzes what interactions people have when they take Glimepiride and Xopenex hfa. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 45,909 Glimepiride users. Check the latest studies of Glimepiride.

What is Xopenex hfa?

Xopenex hfa has active ingredients of levalbuterol tartrate. It is often used in asthma. eHealthMe is studying from 2,529 Xopenex hfa users. Check the latest studies of Xopenex hfa.

On Aug, 09, 2026

12 people who take Glimepiride and Xopenex hfa together, and have interactions are studied.

Glimepiride and Xopenex hfa drug interactions.

What are the common drug interactions of Glimepiride and Xopenex Hfa, by gender? *:

female:

Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
Dyspnoea (difficult or laboured respiration)
Ear infection
Pneumonia
Pulmonary thrombosis (scarring in the lungs)
Confusional state
Death
Dizziness
Epistaxis (bleed from the nose)
Hypoaesthesia (reduced sense of touch or sensation)

male:

Coma (state of unconsciousness lasting more than six hours)
Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
Respiratory failure (inadequate gas exchange by the respiratory system)
Lung neoplasm malignant (cancer tumour of lung)
Pulmonary embolism (blockage of the main artery of the lung)

What are the common drug interactions of Glimepiride and Xopenex Hfa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Hypoaesthesia (reduced sense of touch or sensation)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Surgery

60+:

Coma (state of unconsciousness lasting more than six hours)
Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
Respiratory failure (inadequate gas exchange by the respiratory system)
Death
Lung neoplasm malignant (cancer tumour of lung)
Pulmonary embolism (blockage of the main artery of the lung)

What are the existing conditions these people have? *

Idiopathic Pulmonary Fibrosis (chronic lung disease): 6 people, 50.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 16.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 16.67%
Cardiac Failure Congestive: 2 people, 16.67%
Atrial Thrombosis (blood clot that develops in an artery): 2 people, 16.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
Prostatic Specific Antigen Increased: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Glimepiride and Xopenex hfa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously